The Swiss drugs regulator will delay its approval of the two Covid-19 vaccines developed by AstraZeneca and Johnson & Johnson until it receives more data on their efficacy at preventing the virus, the agency said on Wednesday.
Swissmedic, the country’s regulator, said the current data for the AstraZeneca jab is “not yet sufficient for approval” and it has now called for more information on the vaccine’s “safety, effectiveness and quality.”
Continue reading https://on.rt.com/b100